INFALIN DUO
3MG/ML+0,25MG/ML AUR GTT SOL 10ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 24.07.2019 | |||
Interruption of marketing | 24.06.2019 |
0225143 Lék obtížně nahraditelný (LP s léčivou látkou ciprofloxacin, dle indikací) |
Manufacturing reasons | 18.7.2019 |
Placing on the market | 16.02.2015 |
All reports are available in the Overview.